Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Santora

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Analytical Methods : Advancing Methods and Applications|May 21, 2024
Impact of drug-linker on method selection for analytical characterization and purification of antibody-drug conjugatesLing C Santora, Adrian D Hobson, Lu Wang, et al.
Analytical Biochemistry|December 4, 2001
Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcoreL C Santora, Z Kaymakcalan, P Sakorafas, et al.
Endocrinology|April 1, 1979
Relationship of insulin binding to amino acid transport by cultured 14-day embryonic chick heart cellsA C Santora, F B Wheeler, R L DeHaan, et al.
Bone|May 22, 2020
History of alendronateSteven R Cummings, Arthur C Santora, Dennis M Black, et al.
Skeletal Radiology|January 1, 1983
Cheirolumbar dysostosis: a phenotype of pseudohypoparathyroidismS L Halloran, D B Flannery, M B Kodroff, et al.
Bone|November 4, 2000
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic womenG Y Boivin, P M Chavassieux, A C Santora, et al.
The Journal of Urology|March 1, 1986
Human prostate carcinoma causes hypercalcemia in athymic nude mice and produces a factor with parathyroid hormone-like bioactivityW M Linehan, M L Kish, S L Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Alendronate increases bone mass and reduces bone markers in postmenopausal African-American womenNorman H Bell, John P Bilezikian, Henry G Bone, et al.
Clinical Chemistry|July 1, 1999
Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic womenB C Kress, I A Mizrahi, K W Armour, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 17, 2020
Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosisN Binkley, E Orwoll, R Chapurlat, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Analytical Methods : Advancing Methods and Applications|May 21, 2024
Impact of drug-linker on method selection for analytical characterization and purification of antibody-drug conjugatesLing C Santora, Adrian D Hobson, Lu Wang, et al.
Analytical Biochemistry|December 4, 2001
Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcoreL C Santora, Z Kaymakcalan, P Sakorafas, et al.
Endocrinology|April 1, 1979
Relationship of insulin binding to amino acid transport by cultured 14-day embryonic chick heart cellsA C Santora, F B Wheeler, R L DeHaan, et al.
Bone|May 22, 2020
History of alendronateSteven R Cummings, Arthur C Santora, Dennis M Black, et al.
Skeletal Radiology|January 1, 1983
Cheirolumbar dysostosis: a phenotype of pseudohypoparathyroidismS L Halloran, D B Flannery, M B Kodroff, et al.
Bone|November 4, 2000
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic womenG Y Boivin, P M Chavassieux, A C Santora, et al.
The Journal of Urology|March 1, 1986
Human prostate carcinoma causes hypercalcemia in athymic nude mice and produces a factor with parathyroid hormone-like bioactivityW M Linehan, M L Kish, S L Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Alendronate increases bone mass and reduces bone markers in postmenopausal African-American womenNorman H Bell, John P Bilezikian, Henry G Bone, et al.
Clinical Chemistry|July 1, 1999
Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic womenB C Kress, I A Mizrahi, K W Armour, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 17, 2020
Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosisN Binkley, E Orwoll, R Chapurlat, et al.
Pageof 7